Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of biOsimilaRs in Therapeutic Management of Anemia Following Chemotherapy in HEmatology and Oncology; A Prospective, Observational, Non-interventional Study

NCT02140736 is registered in ClinicalTrials.gov with Hospira, now a wholly owned subsidiary of Pfizer as lead sponsor.

NCT NCT02140736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02140736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of biOsimilaRs in Therapeutic Management of Anemia Following Chemotherapy in HEmatology and Oncology; A Prospective, Observational, Non-interventional Study
Lead sponsor
Hospira, now a wholly owned subsidiary of Pfizer
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
August 1, 2011
Enrollment
2,333 (actual)
Sites
172

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced symptomatic anemia, lymphomas, malignant hemopathies, myelomas, solid tumors